1. Targeting hallmarks of cancer to enhance radiosensitivity in gastrointestinal cancers
    Amy M. Buckley et al, 2020, Nature Reviews Gastroenterology & Hepatology CrossRef
  2. Putative Repurposing of Lamivudine, a Nucleoside/Nucleotide Analogue and Antiretroviral to Improve the Outcome of Cancer and COVID-19 Patients
    José J. García-Trejo et al, 2021, Frontiers in Oncology CrossRef
  3. A single-step O-glycosylation of azidothymidine in bioreactor catalysed by filamentous fungi
    Evilanna L. Arruda et al, 2016, Tetrahedron Letters CrossRef
  4. Novel Cell Receptor System of Eukaryotes Formed by Previously Unknown Nucleic Acid-Based Receptors
    Victor Tetz et al, 2022, Receptors CrossRef
  5. Favipiravir, an antiviral drug, in combination with tamoxifen exerts synergistic effect in tamoxifen-resistant breast cancer cells via hTERT inhibition
    Sally A. Fahim et al, 2024, Scientific Reports CrossRef
  6. Abacavir induces the transcriptional activity of YY1 and other oncogenic transcription factors in gastric cancer cells
    Ponmathi Panneerpandian et al, 2020, Antiviral Research CrossRef
  7. The Anti-Angiogenic Effects of Anti-Human Immunodeficiency Virus Drugs
    Giovanni Barillari, 2020, Frontiers in Oncology CrossRef
  8. Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline—a review
    Shafina Siddiqui et al, 2022, Journal of the Egyptian National Cancer Institute CrossRef
  9. Repurposed Drugs in Gastric Cancer
    Diana Araújo et al, 2022, Molecules CrossRef
  10. Drug rechanneling: A novel paradigm for cancer treatment
    Itishree Kaushik et al, 2021, Seminars in Cancer Biology CrossRef
  11. Lamivudine, Doravirine, and Cabotegravir Downregulate the Expression of Human Endogenous Retroviruses (HERVs), Inhibit Cell Growth, and Reduce Invasive Capability in Melanoma Cell Lines
    Valentina Zanrè et al, 2024, International Journal of Molecular Sciences CrossRef